IE900317L - Use of oxoquinazoline derivatives - Google Patents

Use of oxoquinazoline derivatives

Info

Publication number
IE900317L
IE900317L IE900317A IE31790A IE900317L IE 900317 L IE900317 L IE 900317L IE 900317 A IE900317 A IE 900317A IE 31790 A IE31790 A IE 31790A IE 900317 L IE900317 L IE 900317L
Authority
IE
Ireland
Prior art keywords
oxoquinazoline derivatives
oxoquinazoline
derivatives
Prior art date
Application number
IE900317A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IE900317L publication Critical patent/IE900317L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE900317A 1989-01-30 1990-01-29 Use of oxoquinazoline derivatives IE900317L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3902639A DE3902639A1 (de) 1989-01-30 1989-01-30 Neue verwendung von heterokondensierten oxochinazolinderivaten

Publications (1)

Publication Number Publication Date
IE900317L true IE900317L (en) 1990-07-30

Family

ID=6373044

Family Applications (1)

Application Number Title Priority Date Filing Date
IE900317A IE900317L (en) 1989-01-30 1990-01-29 Use of oxoquinazoline derivatives

Country Status (7)

Country Link
KR (1) KR910700050A (xx)
AU (1) AU5026390A (xx)
CA (1) CA2026318A1 (xx)
DE (1) DE3902639A1 (xx)
IE (1) IE900317L (xx)
IL (1) IL93202A0 (xx)
WO (1) WO1990008546A1 (xx)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3704203A1 (de) * 1987-02-11 1988-08-25 Boehringer Ingelheim Kg Verwendung von oxochinazolinderivaten bei der behandlung der hyperurikaemie

Also Published As

Publication number Publication date
CA2026318A1 (en) 1990-07-31
DE3902639A1 (de) 1990-08-02
KR910700050A (ko) 1991-03-13
IL93202A0 (en) 1990-11-05
WO1990008546A1 (de) 1990-08-09
AU5026390A (en) 1990-08-24

Similar Documents

Publication Publication Date Title
EP0432600A3 (en) Derivatives of 2-iminopyridine
AP9000175A0 (en) 3-substituted-2-oxindole derivatives
EP0430709A3 (en) Benzthiophen derivatives
IL96306A0 (en) Preparation of deoxyfluoronucleosides
EP0431421A3 (en) Heteroarylsubstituted pyridinylpyrimidin derivatives
GB2333292B (en) Derivatives of hexaazoisowurtzitane
GB2229723B (en) Thieno-triazolo-diazepine derivatives
HK64196A (en) New aminopiperazine derivatives
GB2231330B (en) Thieno-triazolo-diazepine derivatives
EP0431424A3 (en) Pyridinylpyrimidin derivatives
GB2229724B (en) Thieno-triazolo-diazepine derivatives
GR900100476A (en) Spirofurane new derivatives
YU53490A (en) Derivatives of tetrahydronaphtaline
EP0479951A4 (en) Bis-acyloxymethyl derivatives
EP0411636A3 (en) Piperidylthiocarbapenem derivatives
GB9015831D0 (en) Dihydropyrimidothiazine derivatives
GB8918275D0 (en) Fluoro-chloro-benzene derivatives
EP0468927A3 (en) Derivatives of carboxymethylcyclopropane
IL95024A0 (en) Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
EP0438686A3 (en) Triazolylmethyl-cyclopropyl derivatives
GB2238310B (en) Selenophen derivatives
IE900317L (en) Use of oxoquinazoline derivatives
GB8918394D0 (en) Preparation of polyhemiacetals
IL89362A0 (en) Preparation of tetrabromotetralin
EP0409296A3 (en) Cardanolactam derivatives